Q3 2023 13F Holders as of 30 Sep 2023
-
Type / Class
-
Equity / Common stock, $0.0001 par value
-
Shares outstanding
-
49.9M
-
Number of holders
-
9
-
Total 13F shares, excl. options
-
137K
-
Shares change
-
+137K
-
Total reported value, excl. options
-
$699K
-
Value change
-
+$699K
-
Number of buys
-
9
-
Price
-
$5.12
Significant Holders of TriSalus Life Sciences, Inc. - Common stock, $0.0001 par value (TLSI) as of Q3 2023
9 filings reported holding TLSI - TriSalus Life Sciences, Inc. - Common stock, $0.0001 par value as of Q3 2023.
TriSalus Life Sciences, Inc. - Common stock, $0.0001 par value (TLSI) has 9 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 137K shares
of 49.9M outstanding shares and own 0.27% of the company stock.
Largest 9 shareholders include Connecticut Wealth Management, LLC (57.2K shares), Anson Capital, Inc. (35K shares), UBS Group AG (24.9K shares), GEODE CAPITAL MANAGEMENT, LLC (17.2K shares), MORGAN STANLEY (1.14K shares), GPS Wealth Strategies Group, LLC (657 shares), WOLVERINE ASSET MANAGEMENT LLC (415 shares), WELLS FARGO & COMPANY/MN (1 shares), and DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) (1 shares).
This table shows the top 9 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.